Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04237545 · ClinicalTrials.gov registry record · NA
A Clinical Study of the T3 Short Dental Implant System
A NA study of Edentulous Jaw, sponsored by ZimVie.
- Completed
- Registry status
- NA
- Development phase
- 106
- Enrollment target
- 4
- Study locations
NCT04237545 is a NA study of Edentulous Jaw that has completed, run by ZimVie. The registered enrollment target is 106 participants. The trial reports 4 study locations across 4 states.
The verdict
NCT04237545, a NA study of Edentulous Jaw, has completed, sponsored by ZimVie.
- COMPLETED
- Registry status
- NA
- Development phase
- 106 participants
- Enrollment target
- 4
- Study locations
Study Summary
This clinical study will evaluate the safety and performance of the T3 short dental implant when placed in the posterior maxilla and mandible.
Conditions Studied
Interventions
- DEVICE T3 short and restoration (prosthesis)
- DEVICE T3 standard length and restoration (prosthesis)
Study Locations (4)
Massachusetts
- Dr. Xiaozhe Han - Boston
Michigan
- Dr. Suheil Boutros - Dearborn Heights
Other
- Dr. Stefano Sivolella - Padua
Catalonia
- Dr. Jordi Gargallo - Tarragona
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2019-10-01 |
| Est. Completion | 2026-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04237545
The ClinicalTrials.gov registry entry for NCT04237545 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 106 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ZimVie, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Edentulous Jaw appearing as the primary indexed condition, and to 2 interventions - of which T3 short and restoration (prosthesis) is the first listed.
NCT04237545 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Massachusetts, Michigan, Other.
Frequently Asked Questions
What is clinical trial NCT04237545 about?
NCT04237545 is a clinical study titled "A Clinical Study of the T3 Short Dental Implant System". This clinical study will evaluate the safety and performance of the T3 short dental implant when placed in the posterior maxilla and mandible.
What is the current status of trial NCT04237545?
This trial is currently completed. It is a NA study. The enrollment target is 106 participants. The study started on 2019-10-01. Estimated completion is 2026-01-31.
What conditions does trial NCT04237545 study?
This clinical trial studies the following conditions: Edentulous Jaw.
What interventions are being tested in trial NCT04237545?
The interventions under investigation include: T3 short and restoration (prosthesis) (DEVICE), T3 standard length and restoration (prosthesis) (DEVICE).
Who is sponsoring clinical trial NCT04237545?
This trial is sponsored by ZimVie, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04237545 being conducted?
This trial has 4 study locations across Massachusetts, Michigan, Catalonia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Edentulous Jaw
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.